Data / Form D filings / Bionano Genomics, Inc.
Bionano Genomics, Inc.: Form D filings
Bionano Genomics, Inc., a biotechnology company in San Diego, CA, filed 12 Form D notices with the SEC between 2010 and 2024. The latest, on July 10, 2024, reports $20 million sold of a $20 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 9540 TOWNE CENTRE DRIVE, SUITE 100, San Diego, CA, 92121
- Phone
- (858) 888-7600
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1411690
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 10, 2024 | New notice | $20,000,001 | $20,000,001 | 2 | Jul 8, 2024 | sec.gov | |
| Jun 5, 2024 | New notice | $20,000,000 | $20,000,000 | 4 | May 24, 2024 | sec.gov | |
| Oct 27, 2023 | New notice | $35,000,000 | $35,000,000 | 1 | Oct 13, 2023 | sec.gov | |
| Oct 25, 2021 | New notice | $41,850,386 | $41,850,386 | 27 | Oct 18, 2021 | sec.gov | |
| Mar 28, 2019 | New notice | $11,500,000 | $2,500,000 | $9,000,000 | 3 | Mar 14, 2019 | sec.gov |
| Jan 27, 2015 | New notice | $68,443,451 | $68,443,451 | 17 | Sep 9, 2014 | sec.gov | |
| Jun 27, 2014 | New notice | $6,139,997 | $5,000,500 | $1,139,497 | 5 | Jun 12, 2014 | sec.gov |
| Jan 8, 2014 | New notice | $15,000 | $15,000 | 1 | Dec 11, 2013 | sec.gov | |
| Oct 2, 2013 | New notice | $13,663,054 | $10,001,000 | $3,662,054 | 5 | Sep 17, 2013 | sec.gov |
| Jul 5, 2012 | New notice | $13,939,494 | $11,573,201 | $2,366,293 | 6 | Jun 20, 2012 | sec.gov |
| Mar 24, 2011 | New notice | $23,265,909 | $23,265,909 | 9 | Mar 15, 2011 | sec.gov | |
| Apr 27, 2010 | New notice | $4,000,000 | $782,314 | $3,217,686 | 3 | Apr 14, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Yvonne L. Linney | Director | |
| Gulsen Erik Kama | Executive Officer | |
| David L. Barker | Director | |
| Kristiina A. Vuori | Director | |
| Christopher A. Twomey | Director | |
| Mark A. Oldakowski | Executive Officer | |
| Jonathan A. Dixon | Executive Officer | |
| Hannah A. Mamuszka | Director | |
| R. Erik Holmlin | Executive Officer, Director | |
| Albert A. Luderer | Director | |
| Vincent A. Wong | Director | |
| Alka A. Chaubey | Executive Officer | |
| Aleksandar A. Rajkovic | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jul 8, 2024 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Bionano Genomics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.